Australia has inked an agreement with British pharmaceutical giant AstraZeneca to supply Australians with the ...
Japan's FUJIFILM Diosynth Biotechnologies, world-leading contract development and manufacturing organization (CDMO) for ...
China's CanSino Biologics Inc. announced on 13 August 2020 that it has successfully listed on the Sci-Tech Innovati...
Australia is progressing with its new and improved Q Fever vaccine at pre-clinical trials following a $1.87 million inje...
The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates h...
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...
Johnson & Johnson on 5 August 2020 announced it's Janssen Pharmaceutical Companies have entered into an agreeme...
Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from ...
American multinational corporation Johnson & Johnson (J&J) has announced that its lead vaccine candidate pr...
Pfizer Inc. and BioNTech SE have announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan ...
The two leading vaccine candidates CanSinoBIO of China and AZD1222 of UK have proven the safety and efficacy a...
The next critical phase for Australia's University of Queensland’s COVID-19 vaccine is underway – with the r...
CanSino Biologics Inc., an innovative biopharmaceutical company dedicated to vaccine R&D and commercialization, has ...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced that its subsidiary Shanghai Fosun Pharmaceutical Industri...
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) th...
The Osaka-based Japanese biotech AnGes Inc. expects its potential COVID-19 vaccine to be ready as early as the first hal...
The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biolog...
South Korea based Genexine has announced that it is the first domestic pharmaceutical company to have been approved for ...
